NIAID | Technology Transfer

HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES

Read more about HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES

European Patent
22831051.2
Filed on 2024-06-26

HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES

Read more about HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES

US Application 18/671,660
Filed on 2024-05-22

HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES

Read more about HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES

Mexico
MX/a/2024/006506
Filed on 2024-05-28

HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES

Read more about HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES

South Korea
10-2024-7021286
Filed on 2024-06-26

HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES

Read more about HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES

China
202280078145.6
Filed on 2024-05-24

HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES

Read more about HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES

Australia
2022399574
Filed on 2024-06-27

HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES

Read more about HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES

Canada
3239461
Filed on 2024-05-28

HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES

Read more about HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES

Japan
2024-532181
Filed on 2024-05-29

COMBINATION TREATMENT REGIMES FOR TREATING CANCER

Read more about COMBINATION TREATMENT REGIMES FOR TREATING CANCER

European Patent
23813192.4
Filed on 2025-05-13

COMBINATION TREATMENT REGIMES FOR TREATING CANCER

Read more about COMBINATION TREATMENT REGIMES FOR TREATING CANCER

US Application 19/183,635
Filed on 2025-04-18

Subscribe to NIAID